Navigation Links
Clinical Update - Debio 025 in Hepatitis C
Date:4/28/2008

ting. Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs.

Founded in 1979 and headquartered in Lausanne, Switzerland, Debiopharm has developed three products with global combined sales in excess of US$2.65 billion in 2007.

For more information on Debiopharm Group, please visit: http://www.debiopharm.com.


'/>"/>
SOURCE The Debiopharm Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
2. ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
3. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
4. More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
5. PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
6. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
9. BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... group of national medical societies launched a multi-state advertising ... and Affordable Care Act, currently under consideration by the ... vote in the coming days. The groups are ... health care bill that is "bad medicine" for patients. ... care system needs reform - but the current Senate ...
(Date:12/16/2009)... WORTH, Texas, Dec. 16 Wound ... a rapidly growing provider of specialty medical ... operating subsidiary is moving toward productization of ... The company currently anticipates products to be ... market, estimated to be a multi-billion dollar ...
(Date:12/16/2009)... HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an ... $1 million in 12% per annum short term debt ... an initial drawdown of $500,000, with accrued interest and ... $500,000 with accrued interest and principal repayable in one ... becoming cashflow positive for any calendar month prior to ...
Breaking Medicine Technology:Physician Groups Oppose Current Senate Health Care Reform Bill 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2Apollo Health Street Collaborates with Client to Develop a CCHIT Certified 08 Ambulatory EMR 48571 1Apollo Health Street Collaborates with Client to Develop a CCHIT Certified 08 Ambulatory EMR 48571 2Highmark Caring Place To Honor Midstate Volunteers 48566 1Highmark Caring Place To Honor Midstate Volunteers 48566 2Highmark Caring Place To Honor Midstate Volunteers 48566 3New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 1New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 2New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 3New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 5New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 6
... 26, 2007 - A new study published,in ... Child Neurology indicates,that a treatment from Medtronic, ... palsy improves their quality of life and ... findings of this Medtronic-sponsored study should,expand access ...
... doctors say they are outraged,over recent media ... hormone to treat a hormone deficiency often ... 2007 /PRNewswire/ -- The adult,use of human ... of a recent New,York Times article about ...
Other Medicine Technology:Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 2Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 3Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 4Doctors Outraged Over Growth Hormone Controversy 2
(Date:12/16/2009)... In an advance that could help ease health and ... reporting development of technology for changing the behavior of ... gateway into the environment. Their study was published in ... Helen Jarvie from the UK Centre for Ecology and ... in the production of nanoparticles particles less than ...
(Date:12/16/2009)... The omega-3 essential fatty acids commonly found in ... overload, according to research published by the American ... the information-processing problems found in people with schizophrenia; ... and other afflictions of the nervous system. ... Behavioral Neuroscience , provides more evidence that fish ...
(Date:12/16/2009)... and Encourage Access to Quality, Cost-Effective Care , ... ... Congress have debated the best ways to rein in runaway costs ... An important part of the ongoing discussion includes how to ... providers besides doctors of medicine (MDs) or osteopathy (DOs). In ...
(Date:12/16/2009)... no direct link has been found, , , WEDNESDAY, Dec. ... -- commonly linked to food poisoning and the stomach ... the cause of some urinary tract infections. , Researchers ... chicken from stores and restaurants and in women with ... germs were transmitted directly to the women through the ...
(Date:12/16/2009)... Reduction Therapy or NSRTSM is found very effective in the ... allergies, asthma, migraines, chronic fatigue and a wide array of ... are using this holistic therapy including over 50 branded BioVeda ... ... Minneapolis, MN (Vocus) December 14, 2009 -- BioVeda Health and ...
Breaking Medicine News(10 mins):Health News:Behavior modification could ease concerns about nanoparticles 2Health News:New study links DHA type of omega-3 to better nervous-system function 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5
... ... growth since 2007, INDIANAPOLIS, May 30 MDwise employees ... plan -- surpassing the 300,000 mark in,membership., In addition to the ... employee base by 182 percent -- going from just,over 50 employees at ...
... YORK, May 30 We know ... to,our skin -- but what about ... Listen to this report from Transitions ... journalists can access video, audio, text, ...
... radicals from hypertension, study finds , , FRIDAY, May 30 ... BH4 may hold promise as a treatment for people with ... BH4 is used to treat a genetic disorder called phenylketonuria ... a molecule called phenylalanine can cause brain damage. , In ...
... Aspects of New Jersey Cases, WHITEHOUSE STATION, N.J., May ... gratified that a Texas appeals court,overturned the August 2005 verdict ... judgment in favor of Merck in the VIOXX product liability,case ... go to trial after the,Company voluntarily removed the medicine from ...
... the University of Calgary shows that smoking while pregnant, ... increased risk of Sudden Infant Death Syndrome (SIDS). Increased ... time or increasing the room temperature can affect the ... to SIDS include babies sleeping in a belly-down position ...
... men,s sexual appetite. But stimulating new research in the ... the eye. A recent study shows that men who ... when they were making decisions about money, soda, and ... and Luk Warlop (KULeuven, Belgium) found that the desire ...
Other Medicine News:Health News:MDwise Enrollment Exceeds 300,000 Members 2Health News:Genetic Disorder Drug Helps Reverse Heart Muscle Enlargement 2Health News:Merck Wins Appeal of First VIOXX(R) Case to go to Trial 2Health News:Merck Wins Appeal of First VIOXX(R) Case to go to Trial 3Health News:New research shows overheating newborns can increase the risk of SIDS 2
The Kowa Non-Contact Tonometer KT-800 comes with a one year parts and labor warranty....
The IR 1000 Insulin Infusion Pump from Animas offers unprecedented safety features, performance, and convenience....
... SpaTouch Pro, powered by LHE, ... multi-application platform. A powerful tool in ... works fast, providing noticeable results usually ... safety in each of its applications, ...
SPR treats pigmented and vascular lesions, skin aging, sun damaged skin and fine lines and wrinkles with clinically proven LHE technology....
Medicine Products: